IBTA Fundamental Analysis - IBOTTA INC-CL A

Fundamental Rating

Taking everything into account, IBTA scores 4 out of 10 in our fundamental rating. IBTA was compared to 91 industry peers in the Media industry. While IBTA has a great health rating, its profitability is only average at the moment. IBTA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

IBTA had positive earnings in the past year.

In the past year IBTA had a positive cash flow from operations.

1.2 Ratios

IBTA's Return On Assets of 14.18% is amongst the best of the industry. IBTA outperforms 97.80% of its industry peers.

Looking at the Return On Equity, with a value of 24.50%, IBTA belongs to the top of the industry, outperforming 95.60% of the companies in the same industry.

IBTA has a Return On Invested Capital of 3.90%. This is in the better half of the industry: IBTA outperforms 60.44% of its industry peers.

		Industry Rank	Sector Rank
ROA	14.18%
ROE	24.5%
ROIC	3.9%

ROA(3y)-2.02%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IBTA has a better Profit Margin (22.92%) than 95.60% of its industry peers.

Looking at the Operating Margin, with a value of 4.65%, IBTA is in line with its industry, outperforming 54.95% of the companies in the same industry.

IBTA's Gross Margin of 80.89% is amongst the best of the industry. IBTA outperforms 95.60% of its industry peers.

		Industry Rank	Sector Rank
OM	4.65%
PM (TTM)	22.92%
GM	80.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBTA is destroying value.

The number of shares outstanding for IBTA has been increased compared to 1 year ago.

IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

IBTA has an Altman-Z score of 2.41. This is not the best score and indicates that IBTA is in the grey zone with still only limited risk for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 2.41, IBTA is in the better half of the industry, outperforming 76.92% of the companies in the same industry.

There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	2.41

ROIC/WACC0.45

WACC8.72%

2.3 Liquidity

IBTA has a Current Ratio of 2.21. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 2.21, IBTA belongs to the best of the industry, outperforming 81.32% of the companies in the same industry.

A Quick Ratio of 2.21 indicates that IBTA has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 2.21, IBTA belongs to the best of the industry, outperforming 82.42% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.21
Quick Ratio	2.21

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1635.56% over the past year.

The Revenue has decreased by -4.42% in the past year.

EPS 1Y (TTM)1635.56%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-90.2%

Revenue 1Y (TTM)-4.42%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-15.58%

3.2 Future

IBTA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -49.91% yearly.

The Revenue is expected to decrease by -1.84% on average over the next years.

EPS Next Y-13.03%

EPS Next 2Y-71.45%

EPS Next 3Y-49.91%

EPS Next 5YN/A

Revenue Next Year-9.54%

Revenue Next 2Y-6.93%

Revenue Next 3Y-1.84%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.70, the valuation of IBTA can be described as expensive.

IBTA's Price/Earnings ratio is a bit cheaper when compared to the industry. IBTA is cheaper than 67.03% of the companies in the same industry.

IBTA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.17.

The Forward Price/Earnings Ratio is negative for IBTA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	26.7
Fwd PE	N/A

4.2 Price Multiples

IBTA's Enterprise Value to EBITDA ratio is in line with the industry average.

Based on the Price/Free Cash Flow ratio, IBTA is valued a bit cheaper than the industry average as 73.63% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	9.57
EV/EBITDA	15.74

4.3 Compensation for Growth

A cheap valuation may be justified as IBTA's earnings are expected to decrease with -49.91% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-71.45%

EPS Next 3Y-49.91%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IBTA!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

IBOTTA INC-CL A

NYSE:IBTA (1/6/2026, 8:04:00 PM)

After market: 22.96 0 (0%)

22.96

+0.26 (+1.15%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)11-12 2025-11-12/amc

Earnings (Next)02-26 2026-02-26

Inst Owners60.63%

Inst Owner Change0%

Ins Owners9.1%

Ins Owner Change1.87%

Market Cap610.28M

Revenue(TTM)352.24M

Net Income(TTM)80.75M

Analysts51.43

Price Target28.85 (25.65%)

Short Float %23.44%

Short Ratio6.95

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)777.32%

Min EPS beat(2)-59.33%

Max EPS beat(2)1613.97%

EPS beat(4)3

Avg EPS beat(4)478.27%

Min EPS beat(4)-59.33%

Max EPS beat(4)1613.97%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-3.58%

Min Revenue beat(2)-6.83%

Max Revenue beat(2)-0.34%

Revenue beat(4)0

Avg Revenue beat(4)-3.61%

Min Revenue beat(4)-6.93%

Max Revenue beat(4)-0.34%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-2.94%

PT rev (3m)-7.04%

EPS NQ rev (1m)0%

EPS NQ rev (3m)203.3%

EPS NY rev (1m)0%

EPS NY rev (3m)77.18%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.1%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.03%

Valuation

		Industry Rank	Sector Rank
PE	26.7
Fwd PE	N/A
P/S	1.73
P/FCF	9.57
P/OCF	6.82
P/B	1.85
P/tB	1.85
EV/EBITDA	15.74

EPS(TTM)0.86

EY3.75%

EPS(NY)-0.18

Fwd EYN/A

FCF(TTM)2.4

FCFY10.45%

OCF(TTM)3.37

OCFY14.66%

SpS13.25

BVpS12.4

TBVpS12.4

PEG (NY)N/A

PEG (5Y)N/A

Graham Number15.49

Profitability

		Industry Rank	Sector Rank
ROA	14.18%
ROE	24.5%
ROCE	4.51%
ROIC	3.9%
ROICexc	10.15%
ROICexgc	10.15%
OM	4.65%
PM (TTM)	22.92%
GM	80.89%
FCFM	18.11%

ROA(3y)-2.02%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover0.62

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	330.28%
Cap/Sales	7.29%
Interest Coverage	72.76
Cash Conversion	370.51%
Profit Quality	78.99%
Current Ratio	2.21
Quick Ratio	2.21
Altman-Z	2.41

F-Score7

WACC8.72%

ROIC/WACC0.45

Cap/Depr(3y)126.83%

Cap/Depr(5y)N/A

Cap/Sales(3y)3.09%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)1635.56%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-90.2%

EPS Next Y-13.03%

EPS Next 2Y-71.45%

EPS Next 3Y-49.91%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.42%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-15.58%

Revenue Next Year-9.54%

Revenue Next 2Y-6.93%

Revenue Next 3Y-1.84%

Revenue Next 5YN/A

EBIT growth 1Y-60.28%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.96%

EBIT Next 3Y17.21%

EBIT Next 5YN/A

FCF growth 1Y629.68%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y410.29%

OCF growth 3YN/A

OCF growth 5YN/A

IBOTTA INC-CL A / IBTA FAQ

What is the ChartMill fundamental rating of IBOTTA INC-CL A (IBTA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IBTA.

Can you provide the valuation status for IBOTTA INC-CL A?

ChartMill assigns a valuation rating of 2 / 10 to IBOTTA INC-CL A (IBTA). This can be considered as Overvalued.

What is the profitability of IBTA stock?

IBOTTA INC-CL A (IBTA) has a profitability rating of 4 / 10.

What are the PE and PB ratios of IBOTTA INC-CL A (IBTA) stock?

The Price/Earnings (PE) ratio for IBOTTA INC-CL A (IBTA) is 26.7 and the Price/Book (PB) ratio is 1.85.

Can you provide the financial health for IBTA stock?

The financial health rating of IBOTTA INC-CL A (IBTA) is 8 / 10.

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

IBOTTA INC-CL A / IBTA FAQ

What is the ChartMill fundamental rating of IBOTTA INC-CL A (IBTA) stock?

Can you provide the valuation status for IBOTTA INC-CL A?

What is the profitability of IBTA stock?

What are the PE and PB ratios of IBOTTA INC-CL A (IBTA) stock?

Can you provide the financial health for IBTA stock?